insights_auto
Outlook: 75.0% bullish·4.2% bearish
Go to analysischevron_right
LILY34:BVMF
Eli Lilly And Company BDR
R$210.50
arrow_downward
-0.89%(-1.88) 1D
Oct 19, 12:09:20 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LILY34...
Open
R$210.50
High
R$211.84
Low
R$209.44
Mkt. cap
1.17T
Avg. vol.
39.61K
Volume
8.72K
52-wk high
R$223.07
52-wk low
R$141.70
Shares outstanding
941.36M
No. of employees
50K
Open
R$210.50
High
R$211.84
Low
R$209.44
Mkt. cap
1.17T
Avg. vol.
39.61K
Volume
8.72K
52-wk high
R$223.07
52-wk low
R$141.70
Shares outstanding
941.36M
No. of employees
50K
News stories
From web sources and news partners
Yahoo Finance
·
53 minutes ago
Eli Lilly's Foundayo to Keep Gaining Market Share Over Next 12 Months, BofA Says
The Motley Fool
·
1 hour ago
Forget Eli Lilly and Novo: This Biotech Could Be a Surprising Winner in the Weight Loss Market
Mugglehead Investment Magazine
·
4 hours ago
Eli Lilly and Company's Omvoh meets pediatric UC endpoint
Investing.com
·
4 hours ago
Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech By Reuters
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company BDR
CEODavid A. Ricks
Employees50K
Founded1876
HeadquartersIndianapolis, Indiana, United States
SectorPharmaceutical industry
Websitelilly.com